Histamine

FDA Drug Profile — Histamine 1522, Positive Skin Test Control - Histamine

Histamine is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including Histamine 1522, Positive Skin Test Control - Histamine. Available dosage forms: liquid, injection.

Drug details

Generic Name
Histamine
Brand Names
Histamine 1522, Positive Skin Test Control - Histamine
Application Number
BLA103891
Sponsor
Professional Complementary Health Formulas
NDC Codes
2
Dosage Forms
LIQUID, INJECTION
Routes
ORAL, PERCUTANEOUS
Active Ingredients
HISTAMINE DIHYDROCHLORIDE, HISTAMINE

Indications and Usage

INDICATIONS AND USAGE Positive Skin Test Control - Histamine is indicated as an adjunct in allergy skin test for diagnosis, as a positive control to test wheal-flare response of skin for evaluation of skin test response to allergenic extracts.

Warnings

WARNINGS Attacks of severe asthma or other serious allergic conditions may be precipitated by the administration of Histamine Dihydrochloride in patients with bronchial disease. Caution is advised in using histamine in such patients and in those with a history of bronchial asthma. Histamine Dihydrochloride has not been approved for unlabeled use as gastric acid stimulus or for detecting bronchial hyperactivity.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.